Alkermes
ALKS
#2383
Rank
HK$60.48 B
Marketcap
HK$359.92
Share price
3.05%
Change (1 day)
41.75%
Change (1 year)

EPS for Alkermes (ALKS)

EPS in 2023 (TTM): HK$10.19

According to Alkermes's latest financial reports the company's current EPS (TTM) is HK$3.14. In 2022 the company made an earnings per share (EPS) of -HK$7.53 a decrease over its 2021 EPS that were of -HK$2.35.

EPS history for Alkermes from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$10.19-235.31%
2022-HK$7.53220%
2021-HK$2.35-57.19%
2020-HK$5.50-44.38%
2019-HK$9.8841.57%
2018-HK$6.98-13.59%
2017-HK$8.08-24.82%
2016-HK$10.74-9.87%
2015-HK$11.92660%
2014-HK$1.57-242.86%
2013HK$1.10-137.84%
2012-HK$2.90-39.34%
2011-HK$4.7824.49%
2010-HK$3.8419.51%
2009-HK$3.21-130.37%
2008HK$10.59-27.81%
2007HK$14.661600%
2006HK$0.86-164.71%
2005-HK$1.33-81.91%
2004-HK$7.37-40.88%
2003-HK$12.478.9%
2002-HK$11.4575.9%
2001-HK$6.513.75%
2000-HK$6.27-37.98%
1999-HK$10.1277.93%
1998-HK$5.68123.08%
1997-HK$2.55-43.97%
1996-HK$4.55

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.42 1,571.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$41.17 1,212.50%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$5.96 90.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$14.92 375.73%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
HK$35.44 1,030.00%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$52.38 1,570.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Acorda Therapeutics
ACOR
-HK$394.50-12,677.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.94 57.50%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel